We are investigating the safety and effects of AZD4063 in adults with dilated cardiomyopathy due to a specific PLN gene mutation. The study aims to see how the drug works in the body and its impact on PLN mRNA levels.
Health conditions and diseases that the clinical trial is designed to study and treat.
Dilated Cardiomyopathy (DCM) is a serious heart condition where the heart's ability to pump blood is decreased due to the enlargement of the heart chambers. This can lead to symptoms such as fatigue, shortness of breath, and swelling in the legs and ankles.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.